Debut Plus

25.5

+0 +0.00%

As of 10 Sept 2026 · delayed

BSE Listed

Hamps Bio Limited (544312)

Volume: 0Avg Vol 1W: 8,800Avg Vol 1M: 8,72752W Range:13.3629.4
Key Ratios
Checked 1h ago
Market Cap
Current Price₹25.5
Previous Close₹25.5
High / Low (52w)₹29.4 / ₹13.36
Volume0
Avg Vol (1W)8,800
Avg Vol (1M)8,727
Stock P/E
Book Value
Dividend Yield
ROE
ROA
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value
EPS (TTM)
P/B
Debt / Equity0.58
50 DMA₹24.89
200 DMA₹23.56
Day change+0.00%
Price Chart
25.5 13.27% · 1Y
361544K
2025-09-11
2026-09-10

20-day avg volume: 9K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 29% YoY.
Cons
  • Company is loss-making at the latest annual result.
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹5 Cr₹6 Cr₹7 Cr₹7 Cr₹9 Cr
EBITDA₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹-1 Cr
EPS0.451.342.550.34-0.85
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4 Cr₹4 Cr₹5 Cr₹13 Cr₹16 Cr
Total Liabilities₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹8 Cr
Equity₹1 Cr₹1 Cr₹3 Cr₹9 Cr₹8 Cr
Total Debt
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹1 Cr₹0 Cr₹-2 Cr₹-1 Cr
Investing₹1 Cr₹-1 Cr₹0 Cr₹-6 Cr₹-3 Cr
Financing₹-1 Cr₹0 Cr₹1 Cr₹8 Cr₹4 Cr
Free Cash Flow₹0 Cr₹1 Cr₹0 Cr₹-2 Cr₹-1 Cr
Shareholding
Promoter 71.99% Institutions 0% Public 28.01%
Efficiency & Working Capital
ROCE
Interest Coverage-1.8
Dividend Payout
Debtor Days68 d
Inventory Days111 d
Payable Days14 d
Cash Conversion Cycle165 d
Working Capital Days179 d
Shareholding Details

As of 2026-03-31

Promoter72%
FII0%
DII0%
Institutions0%
Public28%
Promoter Pledge0%
No. of Shareholders395
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodJul 2024Dec 2024Mar 2025Jun 2025Sept 2025Mar 2026
Promoters100%72%72%72%72%72%
FIIs0%0.2%0%0%0%0%
DIIs0%0%0%0%0%0%
Public0%27.8%28%28%28%28%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders9589410399395395
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Herrik Mountbaton ShahShareholding of Promoter and Promoter Group31.1%27,10,768
Shrenik Mountkumar ShahShareholding of Promoter and Promoter Group23.6%20,52,682
Herrik Mountbaton Shah HufShareholding of Promoter and Promoter Group5.3%4,58,908
Mountbaton S Shah HufShareholding of Promoter and Promoter Group3.4%2,97,840
Pallavi Herrik ShahShareholding of Promoter and Promoter Group3.4%2,94,714
Shrenik Mountkumar Shah HufShareholding of Promoter and Promoter Group2.9%2,56,240
Narayanan OttappathPublic Shareholding2.3%2,00,000
Anil Gurmukh BhagwaniPublic Shareholding1.6%1,36,000
Bhavya Herrik ShahShareholding of Promoter and Promoter Group1.5%1,28,000
Mitali Shrenikkumar ShahShareholding of Promoter and Promoter Group0.7%64,000
Alkaben Mountbaton ShahShareholding of Promoter and Promoter Group0.1%8,848
Board of Directors
NameDesignationYear
HERRIK MOUNTBATON SHAHChairman & Managing Director2025
Shrenik ShahWhole-time Director2025
Pallavi ShahNon Executive Director2025
Jinay PalrechaIndependent Non Exe. Director2025
Radhika Arun KanodiyaIndependent Non Exe. Director2025
Segments — Product
SegmentRevenueShare
Pharma Products₹4 Cr52.1%
Freeze dried Products₹4 Cr47.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101099
Corporate Actions
TypeDateValueRemark
bonus2025-09-081:11:1 Bonus Issue of Equity Shares
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025010203
2025000101
2025000000
Company Information
Incorporated2007
ChairmanHERRIK MOUNTBATON SHAH
AuditorM G H V S & ASSOCIATES
Investor Email[email protected]
🌐 www.hampsbio.com

📍 2900/112 GIDC Near Atul Ltd, Ankelshwar, Bharuch, Gujarat, 393002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search